Short Interest in Luye Pharma Group Ltd. (OTCMKTS:LYPHF) Drops By 25.3%

Luye Pharma Group Ltd. (OTCMKTS:LYPHF) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 18,511,300 shares, a drop of 25.3% from the May 31st total of 24,779,800 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Luye Pharma Group Price Performance

LYPHF stock remained flat at $0.37 during midday trading on Friday. The company has a 50 day simple moving average of $0.38 and a 200-day simple moving average of $0.39. Luye Pharma Group has a twelve month low of $0.37 and a twelve month high of $0.37.

About Luye Pharma Group

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia.